Kingstone Capital Partners Texas, LLC Bristol Myers Squibb CO Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 2,136,479 shares of BMY stock, worth $102 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,136,479Holding current value
$102 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,795Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.12 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.56 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.15 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.52 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.17 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $101B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...